{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:11:34Z","timestamp":1792627894849,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T00:00:00Z","timestamp":1517270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1038\/bjc.2017.447","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T21:01:13Z","timestamp":1517346073000},"page":"713-726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein"],"prefix":"10.1038","volume":"118","author":[{"given":"Urszula L","family":"McClurg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Nabbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ricordel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana","family":"Korolchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Heer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn Kate","family":"Irving-Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Pedeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig N","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl T","family":"Riabowol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Binda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"issue":"4","key":"BFbjc2017447_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","volume":"129","author":"A Barski","year":"2007","unstructured":"Barski A, Cuddapah S, Cui K, Roh T-Y, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K (2007) High-resolution profiling of histone methylations in the human genome. Cell 129 (4): 823\u2013837.","journal-title":"Cell"},{"issue":"25","key":"BFbjc2017447_CR2","doi-asserted-by":"publisher","first-page":"17599","DOI":"10.1074\/jbc.274.25.17599","volume":"274","author":"ME Brady","year":"1999","unstructured":"Brady ME, Ozanne DM, Gaughan L, Waite I, Cook S, Neal DE, Robson CN (1999) Tip60 is a nuclear hormone receptor coactivator. J Biol Chem 274 (25): 17599\u201317604.","journal-title":"J Biol Chem"},{"issue":"5","key":"BFbjc2017447_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/138945009788185112","volume":"10","author":"DJ Bua","year":"2009","unstructured":"Bua DJ, Binda O (2009) The return of the INGs, histone mark sensors and phospholipid signaling effectors. Curr Drug Targets 10 (5): 418\u2013431.","journal-title":"Curr Drug Targets"},{"issue":"45","key":"BFbjc2017447_CR4","doi-asserted-by":"publisher","first-page":"32641","DOI":"10.1074\/jbc.M113.485912","volume":"288","author":"UL Burska","year":"2013","unstructured":"Burska UL, Harle VJ, Coffey K, Darby S, Ramsey H, O'Neill D, Logan IR, Gaughan L, Robson CN (2013) Deubiquitinating enzyme Usp12 is a novel co-activator of the androgen receptor. J Biol Chem 288 (45): 32641\u201332650.","journal-title":"J Biol Chem"},{"issue":"13","key":"BFbjc2017447_CR5","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1158\/1078-0432.CCR-12-0782","volume":"18","author":"MM Centenera","year":"2012","unstructured":"Centenera MM, Gillis JL, Hanson AR, Jindal S, Taylor RA, Risbridger GP, Sutherland PD, Scher HI, Raj GV, Knudsen KE, Yeadon T, Tilley WD, Butler LM (2012) Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors. Clin Cancer Res 18 (13): 3562\u20133570.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"BFbjc2017447_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrurol.2013.126","volume":"10","author":"MM Centenera","year":"2013","unstructured":"Centenera MM, Raj GV, Knudsen KE, Tilley WD, Butler LM (2013) Ex vivo culture of human prostate tissue and drug development. Nat Rev Urol 10 (8): 483\u2013487.","journal-title":"Nat Rev Urol"},{"issue":"5","key":"BFbjc2017447_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2 (5): 401\u2013404.","journal-title":"Cancer Discov"},{"issue":"10","key":"BFbjc2017447_CR8","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/onc.2009.424","volume":"29","author":"G Chen","year":"2010","unstructured":"Chen G, Wang Y, Garate M, Zhou J, Li G (2010) The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system. Oncogene 29 (10): 1498\u20131508.","journal-title":"Oncogene"},{"issue":"8","key":"BFbjc2017447_CR9","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1093\/nar\/gkt106","volume":"41","author":"K Coffey","year":"2013","unstructured":"Coffey K, Rogerson L, Ryan-Munden C, Alkharaif D, Stockley J, Heer R, Sahadevan K, O'Neill D, Jones D, Darby S, Staller P, Mantilla A, Gaughan L, Robson CN (2013) The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover. Nucleic Acids Res 41 (8): 4433\u20134446.","journal-title":"Nucleic Acids Res"},{"issue":"25","key":"BFbjc2017447_CR10","doi-asserted-by":"publisher","first-page":"11423","DOI":"10.1073\/pnas.0912116107","volume":"107","author":"AH Coles","year":"2010","unstructured":"Coles AH, Gannon H, Cerny A, Kurt-Jones E, Jones SN (2010) Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity. Proc Natl Acad Sci USA 107 (25): 11423\u201311428.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"BFbjc2017447_CR11","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1158\/0008-5472.CAN-06-3558","volume":"67","author":"AH Coles","year":"2007","unstructured":"Coles AH, Liang H, Zhu Z, Marfella CGA, Kang J, Imbalzano AN, Jones SN (2007) Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis. Cancer Res 67 (5): 2054\u20132061.","journal-title":"Cancer Res"},{"issue":"1","key":"BFbjc2017447_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.molcel.2005.12.007","volume":"21","author":"Y Doyon","year":"2006","unstructured":"Doyon Y, Cayrou C, Ullah M, Landry A-J, C\u00f4t\u00e9 V, Selleck W, Lane WS, Tan S, Yang X-J, C\u00f4t\u00e9 J (2006) ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell 21 (1): 51\u201364.","journal-title":"Mol Cell"},{"issue":"5","key":"BFbjc2017447_CR13","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1128\/MCB.24.5.1884-1896.2004","volume":"24","author":"Y Doyon","year":"2004","unstructured":"Doyon Y, Selleck W, Lane WS, Tan S, C\u00f4t\u00e9 J (2004) Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Mol Cell Biol 24 (5): 1884\u20131896.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"BFbjc2017447_CR14","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (5): E359\u2013E386.","journal-title":"Int J Cancer"},{"issue":"14","key":"BFbjc2017447_CR15","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/onc.2014.115","volume":"34","author":"R Ferraldeschi","year":"2015","unstructured":"Ferraldeschi R, Welti J, Luo J, Attard G, de Bono JS (2015) Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects. Oncogene 34 (14): 1745\u20131757.","journal-title":"Oncogene"},{"issue":"269","key":"BFbjc2017447_CR16","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6 (269): pl1.","journal-title":"Sci Signal"},{"issue":"4","key":"BFbjc2017447_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ng1296-415","volume":"14","author":"I Garkavtsev","year":"1996","unstructured":"Garkavtsev I, Kazarov A, Gudkov A, Riabowol K (1996) Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat Genet 14 (4): 415\u2013420.","journal-title":"Nat Genet"},{"issue":"29","key":"BFbjc2017447_CR18","doi-asserted-by":"publisher","first-page":"25904","DOI":"10.1074\/jbc.M203423200","volume":"277","author":"L Gaughan","year":"2002","unstructured":"Gaughan L, Logan IR, Cook S, Neal DE, Robson CN (2002) Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. J Biol Chem 277 (29): 25904\u201325913.","journal-title":"J Biol Chem"},{"issue":"2","key":"BFbjc2017447_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.molcel.2008.12.016","volume":"33","author":"T Hung","year":"2009","unstructured":"Hung T, Binda O, Champagne KS, Kuo AJ, Johnson K, Chang HY, Simon MD, Kutateladze TG, Gozani O (2009) ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation. Mol Cell 33 (2): 248\u2013256.","journal-title":"Mol Cell"},{"issue":"2","key":"BFbjc2017447_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1006\/viro.1996.0071","volume":"216","author":"J Kamine","year":"1996","unstructured":"Kamine J, Elangovan B, Subramanian T, Coleman D, Chinnadurai G (1996) Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology 216 (2): 357\u2013366.","journal-title":"Virology"},{"issue":"3","key":"BFbjc2017447_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nprot.2009.2","volume":"4","author":"LA Kelley","year":"2009","unstructured":"Kelley LA, Sternberg MJE (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4 (3): 363\u2013371.","journal-title":"Nat Protoc"},{"issue":"6","key":"BFbjc2017447_CR22","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/sj.onc.1209118","volume":"25","author":"JV Kichina","year":"2006","unstructured":"Kichina JV, Zeremski M, Aris L, Gurova KV, Walker E, Franks R, Nikitin AY, Kiyokawa H, Gudkov AV (2006) Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas. Oncogene 25 (6): 857\u2013866.","journal-title":"Oncogene"},{"issue":"35","key":"BFbjc2017447_CR23","doi-asserted-by":"publisher","first-page":"18326","DOI":"10.1074\/jbc.M115.690651","volume":"291","author":"S Kim","year":"2016","unstructured":"Kim S, Natesan S, Cornilescu G, Carlson S, Tonelli M, McClurg UL, Binda O, Robson CN, Markley JL, Balaz S, Glass KC (2016) Mechanism of histone H3K4me3 recognition by the plant homeodomain of inhibitor of growth 3. J Biol Chem 291 (35): 18326\u201318341.","journal-title":"J Biol Chem"},{"issue":"7","key":"BFbjc2017447_CR24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1365-2559.2006.02412.x","volume":"48","author":"T Kirkegaard","year":"2006","unstructured":"Kirkegaard T, Edwards J, Tovey S, McGlynn LM, Krishna SN, Mukherjee R, Tam L, Munro AF, Dunne B, Bartlett JM (2006) Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology 48 (7): 787\u2013794.","journal-title":"Histopathology"},{"issue":"2","key":"BFbjc2017447_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00109-012-0949-1","volume":"91","author":"R Kuner","year":"2013","unstructured":"Kuner R, Falth M, Pressinotti NC, Brase JC, Puig SB, Metzger J, Gade S, Schafer G, Bartsch G, Steiner E, Klocker H, Sultmann H (2013) The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer. J Mol Med 91 (2): 237\u2013248.","journal-title":"J Mol Med"},{"issue":"11","key":"BFbjc2017447_CR26","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1210\/endo.140.11.7086","volume":"140","author":"S Lu","year":"1999","unstructured":"Lu S, Tsai SY, Tsai MJ (1999) Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells. Endocrinology 140 (11): 5054\u20135059.","journal-title":"Endocrinology"},{"issue":"Pt 4","key":"BFbjc2017447_CR27","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1107\/S0907444911007281","volume":"67","author":"S McNicholas","year":"2011","unstructured":"McNicholas S, Potterton E, Wilson KS, Noble ME (2011) Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr D Biol Crystallogr 67 (Pt 4): 386\u2013394.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"5","key":"BFbjc2017447_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejcb.2015.03.002","volume":"94","author":"A Nabbi","year":"2015","unstructured":"Nabbi A, Almami A, Thakur S, Suzuki K, Boland D, Bismar TA, Riabowol K (2015) ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal. Eur J Cell Biol 94 (5): 214\u2013222.","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"BFbjc2017447_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12916-017-0854-0","volume":"15","author":"A Nabbi","year":"2017","unstructured":"Nabbi A, McClurg UL, Thalappilly S, Almami A, Mobahat M, Bismar TA, Binda O, Riabowol KT (2017) ING3 promotes prostate cancer growth by activating the androgen receptor. BMC Med 15 (1): 103.","journal-title":"BMC Med"},{"issue":"3","key":"BFbjc2017447_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/sj.onc.1206115","volume":"22","author":"M Nagashima","year":"2003","unstructured":"Nagashima M, Shiseki M, Pedeux RM, Okamura S, Kitahama-Shiseki M, Miura K, Yokota J, Harris CC (2003) A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis. Oncogene 22 (3): 343\u2013350.","journal-title":"Oncogene"},{"issue":"7","key":"BFbjc2017447_CR31","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4161\/epi.28864","volume":"9","author":"DJ O'Neill","year":"2014","unstructured":"O'Neill DJ, Williamson SC, Alkharaif D, Monteiro ICM, Goudreault M, Gaughan L, Robson CN, Gingras A-C, Binda O (2014) SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells. Epigenetics 9 (7): 942\u2013950.","journal-title":"Epigenetics"},{"issue":"7485","key":"BFbjc2017447_CR32","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature12922","volume":"505","author":"A Obri","year":"2014","unstructured":"Obri A, Ouararhni K, Papin C, Diebold M-L, Padmanabhan K, Marek M, Stoll I, Roy L, Reilly PT, Mak TW, Dimitrov S, Romier C, Hamiche A (2014) ANP32E is a histone chaperone that removes H2A.Z from chromatin. Nature 505 (7485): 648\u2013653.","journal-title":"Nature"},{"issue":"5","key":"BFbjc2017447_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrm2395","volume":"9","author":"T Riley","year":"2008","unstructured":"Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9 (5): 402\u2013412.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"BFbjc2017447_CR34","doi-asserted-by":"publisher","first-page":"e15541","DOI":"10.1371\/journal.pone.0015541","volume":"5","author":"M Saito","year":"2010","unstructured":"Saito M, Kumamoto K, Robles AI, Horikawa I, Furusato B, Okamura S, Goto A, Yamashita T, Nagashima M, Lee T-L, Baxendale VJ, Rennert OM, Takenoshita S, Yokota J, Sesterhenn IA, Trivers GE, Hussain SP, Harris CC (2010) Targeted disruption of Ing2 results in defective spermatogenesis and development of soft-tissue sarcomas. PLoS One 5 (11): e15541.","journal-title":"PLoS One"},{"issue":"7098","key":"BFbjc2017447_CR35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature04835","volume":"442","author":"X Shi","year":"2006","unstructured":"Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T, Carney D, Pe\u00f1a P, Lan F, Kaadige MR, Lacoste N, Cayrou C, Davrazou F, Saha A, Cairns BR, Ayer DE, Kutateladze TG, Shi Y, C\u00f4t\u00e9 J, Chua KF, Gozani O (2006) ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442 (7098): 96\u201399.","journal-title":"Nature"},{"issue":"21","key":"BFbjc2017447_CR36","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.18632\/oncotarget.2511","volume":"5","author":"T Wang","year":"2014","unstructured":"Wang T, Guo S, Liu Z, Wu L, Li M, Yang J, Chen R, Liu X, Xu H, Cai S, Chen H, Li W, Xu S, Wang L, Hu Z, Zhuang Q, Wang L, Wu K, Liu J, Ye Z, Ji J-Y, Wang C, Chen K (2014a) CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling. Oncotarget 5 (21): 10293\u201310306.","journal-title":"Oncotarget"},{"issue":"11","key":"BFbjc2017447_CR37","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.18632\/oncotarget.1968","volume":"5","author":"T Wang","year":"2014","unstructured":"Wang T, Liu Z, Guo S, Wu L, Li M, Yang J, Chen R, Xu H, Cai S, Chen H, Li W, Wang L, Hu Z, Zhuang Q, Xu S, Wang L, Liu J, Ye Z, Ji J-Y, Wang C, Chen K (2014b) The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer. Oncotarget 5 (11): 3611\u20133621.","journal-title":"Oncotarget"},{"issue":"6","key":"BFbjc2017447_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrclinonc.2014.72","volume":"11","author":"YNS Wong","year":"2014","unstructured":"Wong YNS, Ferraldeschi R, Attard G, de Bono J (2014) Evolution of androgen receptor targeted therapy for advanced prostate cancer. Nat Rev Clin Oncol 11 (6): 365\u2013376.","journal-title":"Nat Rev Clin Oncol"},{"issue":"49","key":"BFbjc2017447_CR39","doi-asserted-by":"publisher","first-page":"30595","DOI":"10.1074\/jbc.272.49.30595","volume":"272","author":"T Yamamoto","year":"1997","unstructured":"Yamamoto T, Horikoshi M (1997) Novel substrate specificity of the histone acetyltransferase activity of HIV-1-Tat interactive protein Tip60. J Biol Chem 272 (49): 30595\u201330598.","journal-title":"J Biol Chem"},{"issue":"6","key":"BFbjc2017447_CR40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.7150\/jca.11404","volume":"6","author":"H Zhou","year":"2015","unstructured":"Zhou H, Wang L, Huang J, Jiang M, Zhang X, Zhang L, Wang Y, Jiang Z, Zhang Z (2015) High EGFR_1 inside-out activated inflammation-induced motility through SLC2A1-CCNB2-HMMR-KIF11-NUSAP1-PRC1-UBE2C. J Cancer 6 (6): 519\u2013524.","journal-title":"J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2017447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017447","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bjc.2017.447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:40:49Z","timestamp":1684417249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2017447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["BFbjc2017447"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2017.447","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,30]]},"assertion":[{"value":"28 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}